Course Evaluations for Lymphoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Lymphoma+3 More
Course Evaluations - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new method to help doctors communicate better with elderly patients and their caregivers.

Eligible Conditions
  • Lymphoma
  • Cancer Gi
  • GU Cancer
  • Bone Marrow Transplantation

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Lymphoma

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 8 weeks

1 week
Participants satisfaction with Health Care Provider (HCP) training
8 weeks
Feasibility of Health Care Provider (HCP) training

Trial Safety

Safety Progress

1 of 3

Other trials for Lymphoma

Trial Design

3 Treatment Groups

Caregivers of Participants with GI/GU/Lymphoma Cancer
1 of 3
Participants with GI/GU/Lymphoma Cancer
1 of 3
GI/GU/Lymphoma Oncologists
1 of 3
Active Control
Experimental Treatment

88 Total Participants · 3 Treatment Groups

Primary Treatment: Course Evaluations · No Placebo Group · N/A

GI/GU/Lymphoma OncologistsExperimental Group · 3 Interventions: Course Evaluations, Self-Efficacy Assessment, UCLA Geriatrics Attitudes Scale · Intervention Types: Behavioral, Behavioral, Behavioral
Caregivers of Participants with GI/GU/Lymphoma CancerActiveComparator Group · 2 Interventions: Consumer Assessment of Health Care Providers and Systems Program (CAHPS), The Consultation and Relational Empathy (CARE) questionnaire · Intervention Types: Behavioral, Behavioral
Participants with GI/GU/Lymphoma CancerActiveComparator Group · 3 Interventions: Consumer Assessment of Health Care Providers and Systems Program (CAHPS), Patient activation measure (PAM) scale, The Consultation and Relational Empathy (CARE) questionnaire · Intervention Types: Behavioral, Behavioral, Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,821 Previous Clinical Trials
584,259 Total Patients Enrolled
148 Trials studying Lymphoma
7,724 Patients Enrolled for Lymphoma
Smita Banerjee, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
4 Previous Clinical Trials
1,365 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to be audio-recorded as per self-report.
You are aged 65 years or over, and you have had a new visit within the last 6 months.
You are a woman aged 65 years or over.
You are seen by one of the consented HCPs as per the HCP and/or EMR.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 27th, 2021

Last Reviewed: October 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.